Fujirebio Europe

Foundation date

18/07/1985

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states.

Upcoming events

Latest news

  • Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

    Thursday October 17th 2024

  • InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research

    Wednesday October 16th 2024

  • A brown ale or hoppy lager? Even fruit flies have a preference.

    Tuesday October 15th 2024